Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin

Posted : Mon, 09 Nov 2009 11:28:27 GMT
Author : Simcere Pharmaceutical Group
Category : Press Release
News Alerts by Email ( click here )
News | Home
NANJING, China, Nov. 9 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced an agreement to acquire the manufacturing license in China of Rosuvastatin from Tianjin Tianda Pharmaceutical Co., Ltd. ("Tianda"). The acquisition of the manufacturing license will be effected through the acquisition of equity in Tianda as well as transfer of certain technologies from Tianda. Rosuvastatin was first marketed by Astrazeneca as Crestor in 2003 and is an effective statin to treat high cholesterol and related conditions.
Upon completion of the acquisition, Simcere will start manufacturing Rosuvastatin.
Mr. Jinsheng Ren, Chairman and Chief Executive Officer of Simcere Pharmaceutical Group commented on the agreement, "We are delighted to join forces with Tianda to manufacture Rosuvastatin in China. Rosuvastatin has huge market potential and we believe that with our marketing expertise we can help more heart disease patients in China benefit from this drug."
Safe Harbor Statement
This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions. These forward looking statements are based upon management's current views and expectations with respect to future events and are not a guarantee of future performance. Furthermore, these statements are, by their nature, subject to a number of risks and uncertainties that could cause actual performance and results to differ materially from those discussed in the forward-looking statements as a result of a number of factors. Further information regarding these and other risks is included in Simcere's filings with the U.S. Securities and Exchange Commission at http://www.sec.gov . Simcere does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
About Simcere Pharmaceutical Group
Simcere Pharmaceutical Group (NYSE:SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China. In recent years, Simcere has been focusing its strategy on the development of innovative pharmaceuticals and first-to-market generics, and has introduced an innovative anti-cancer medication Endu, a first-to-market medication Sinofuan, and first-to-market generics such as Bicun and Anxin. Simcere manufactures and sells anti-infective medication, anti-cancer medication and stroke management medication. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, orthopaedics and infectious diseases. For more information about Simcere Pharmaceutical Group, please visit http://www.simcere.com .
SOURCE Simcere Pharmaceutical Group

Copyright © 2008 PR Newswire. All rights reserved.

Share/Save/Bookmark

Article : Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

Windstar Cruises Voted 'Most Romantic Cruise Line' for Fifth Time by Porthole Cruise Magazine Readers in Annual Awards
SEATTLE, Nov. 23 /PRNewswire/ -- Windstar Cruises, which operates a three-ship fleet of luxury yachts that explore hidden harbors and secluded coves of the world's most treasured destinations, has been recognized by Porthole Cruise Magazine as the "Most Romantic Cruise Line&...

Research and Markets: 2009 Analysis - Dairy Equipment - A Comprehensive Profile of 93 Companies Operating In the UK Market Is Designed To Alert You to Merger and Acquisition Activity
DUBLIN - Research and Markets (

Wildcat Announces Drill Results
VANCOUVER, BRITISH COLUMBIA -- 11/23/09 -- Wildcat Silver Corporation (TSX VENTURE: WS) ("Wildcat" or "the Company") announces drill results for nine step out holes drilled on its 80%-owned Hardshell property in southern Arizona. Three holes were d..

FONAR Announces Financial Results for First Quarter of Fiscal 2010
MELVILLE, NY -- 11/23/09 -- FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning(TM), today announced its financial results for the first quarter of fiscal 2010, which ended September 30, 2009. The loss from operations improved 23% from a ..

Reportlinker Adds Hydrokinetic and Ocean Energy
NEW YORK, Nov. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Hydrokinetic and Ocean Energy

Reportlinker Adds Lithium Batteries - Global Market Opportunities
NEW YORK, Nov. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Lithium Batteries - Global Market Opportunities...

Con Edison Saluted for Contributions to Westchester
NEW YORK, NY -- 11/23/09 -- The Association of Development Officers (ADO) has recognized Con Edison with its 2009 award for "Outstanding Corporate Philanthropy" in Westchester County. ADO cited the diverse organizations the company suppor..

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.